Skip to main content

Table 2 Carotid atherosclerosis after 13-years in subjects with and without metabolic syndrome, by age

From: The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study

  Metabolic syndrome Metabolic syndrome
  Yes No   Yes No  
Age, years N IMT, mm N IMT, mm P* N TPA, mm2 N TPA, mm2 P*
0-49 81 0.940 483 0.818 <0.0001 79 10.748 479 5.737 0.0001
50-59 224 1.014 965 0.964 <0.0001 218 18.146 956 14.569 0.02
60-69 213 1.088 835 1.041 0.008 209 25.494 830 21.814 0.06
≥70 32 1.135 101 1.059 0.09 31 28.647 99 24.543 0.46
Total 550 1.039 2384 0.966 <0.0001 537 20.524 2364 15.740 <0.0001
Age, years N ΔIMT, mm N ΔIMT, mm P* N ΔTPA, mm2 N ΔTPA, mm2 P*
0-49 81 0.185 483 0.143 0.009 79 7.858 477 4.031 0.0006
50-59 222 0.169 965 0.160 0.5 218 9.857 953 9.203 0.6
60-69 208 0.195 832 0.176 0.2 208 15.363 826 13.116 0.4
≥70 32 0.157 101 0.126 0.5 31 10.951 99 11.227 0.9
Total 543 0.178 2381 0.165 0.13 536 11.763 2355 9.613 0.02
  1. * p for differences between subjects with and without metabolic syndrome.
  2. IMT; intima-media thickness at follow-up, TPA; total plaque area at follow-up, ΔIMT; change in intima-media thickness from baseline to follow-up, ΔTPA; change in total plaque area from baseline to follow-up.
  3. The Tromsø Study.